Channel Therapeutics Corporation (CHRO)
NYSEAMERICAN: CHRO · Real-Time Price · USD
1.360
-0.010 (-0.73%)
At close: Apr 25, 2025, 4:00 PM
1.290
-0.070 (-5.15%)
Pre-market: Apr 28, 2025, 4:22 AM EDT
Channel Therapeutics Market Cap
Channel Therapeutics has a market cap or net worth of $8.30 million as of April 28, 2025. Its market cap has decreased by -22.41% in one year.
Market Cap
8.30M
Enterprise Value
9.97M
1-Year Change
-22.41%
Ranking
Category
Stock Price
$1.36
Market Cap Chart
Since the IPO on February 16, 2024, Channel Therapeutics's market cap has decreased from $33.50M to $8.30M, a decrease of -75.22%. That is a compound annual growth rate of -69.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 8.30M | 114.84% |
| Dec 31, 2024 | 3.86M | -88.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |